December 31, 2025

A new immunotherapy approach could work for many types of cancer

December 31, 2025 / Research update / InnovateMed Author / cancer

Posted Today Researchers at MIT and Stanford University have developed a new way to stimulate the immune system to attack tumor cells, using a strategy that could make cancer immunotherapy work for many more patients. Researchers showed they could stimulate a strong anti-tumor immune response by using molecules called AbLecs, represented here in the center, that block an […]

A new immunotherapy approach could work for many types of cancer Read More »

New robotic skin lets humanoid robots sense pain and react instantly

December 31, 2025 / Research update / InnovateMed Author / robotic skin

by Paul Arnold, Phys.org edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes Modular, neuromorphic electronic skin capable of active pain and injury perception in robotic applications. Credit: Xinge Yu, City University of Hong Kong If you accidentally put your hand on a hot object, you’ll naturally pull it away fast, before you have to think about

New robotic skin lets humanoid robots sense pain and react instantly Read More »

FDA Expands Flibanserin Approval to Postmenopausal Women With Hypoactive Sexual Desire Disorder

December 31, 2025 / Clinical Practice / InnovateMed Author / sexual desire disorder

Tara Haelle December 23, 2025 Flibanserin (Addyi), the drug manufactured by Sprout Pharmaceuticals for the treatment of hypoactive sexual desire disorder (HSDD), received approval from the FDA for use in postmenopausal women up to age 64 last week. The medication was first approved a decade ago for premenopausal women, but no FDA-approved pharmacologic options have

FDA Expands Flibanserin Approval to Postmenopausal Women With Hypoactive Sexual Desire Disorder Read More »

AI-powered RNA drug development: a new frontier in therapeutics

December 31, 2025 / Research update / InnovateMed Author / therapeutics

Peer-Reviewed Publication Higher Education Press image: (a) Success rate, timeline, and cost (in billions) of traditional drug development versus RNA drug development, along with a description of the evolutionary progress of the latter. (b) The future paradigm of AI-driven RNA drug development, characterized by interactive software and a closed loop of upstream drug design and

AI-powered RNA drug development: a new frontier in therapeutics Read More »

Patient Extortion: What Doctors Should Do

December 31, 2025 / Clinical Practice / InnovateMed Author / extortion

Ericka L. Adler, JD, LLM DISCLOSURES December 24, 2025 To submit a legal/professional healthcare question for future consideration, write to the editor at legalcorner@medscape.net (include “Ask the Expert” in subject line). Hi, everyone. I’m Ericka Adler, shareholder and leader of the healthcare practice at Roetzel & Andress. Have you ever had a patient make — or threaten to

Patient Extortion: What Doctors Should Do Read More »

Spherical Ablation Catheter Provides Unprecedented Control of Atrial Fibrillation at 1 Year

December 31, 2025 / Research update / InnovateMed Author / atrial fibrillation

Ted Bosworth June 26, 2025 SAN DIEGO — Building on the success of a growing number of devices employing pulsed field ablation to control treatment-resistant paroxysmal atrial fibrillation (AF), a new spherical device produced the highest rate so far of sustained pulmonary vein isolation and freedom from the arrhythmia at 1 year. The results, characterized

Spherical Ablation Catheter Provides Unprecedented Control of Atrial Fibrillation at 1 Year Read More »

Aging-related weight gain in women: It may start earlier in life than you think

December 31, 2025 / Patient education / InnovateMed Author / aging

by Sharon Theimer, Mayo Clinic edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes Credit: Pixabay/CC0 Public Domain Weight gain is common in women during perimenopause and after menopause, but the physical changes underlying it start much earlier in adulthood. Daniela Hurtado Andrade, M.D., Ph.D., an endocrinologist and obesity expert at Mayo Clinic in Jacksonville, explains why

Symptoms of a heart attack may emerge weeks beforehand: What to know

December 31, 2025 / Patient education / InnovateMed Author / heart attack

by Dpa edited by Stephanie Baum, reviewed by Andrew Zinin Credit: CC0 Public Domain A heart attack is a medical emergency that requires an immediate call to the emergency services. However, there are sometimes warning signs that can show up weeks in advance that should prompt you to visit your doctor. Firstly, what exactly happens during a

Symptoms of a heart attack may emerge weeks beforehand: What to know Read More »

Visiting abroad in the coming year? Antibiotics becoming less effective against traveler’s diarrhea, study warns

December 31, 2025 / Research update / InnovateMed Author / diarhhea

by Dennis Thompson edited by Stephanie Baum, reviewed by Andrew Zinin Planning some international travel as one of your New Year’s resolutions? Then be forewarned: Travelers’ diarrhea is becoming harder to treat. The antibiotics typically used to treat travelers’ diarrhea are becoming less effective, researchers recently reported in JAMA Network Open. Specifically, the bacteria that cause the illness

Visiting abroad in the coming year? Antibiotics becoming less effective against traveler’s diarrhea, study warns Read More »

FDA approves Jascayd for progressive pulmonary fibrosis

December 31, 2025 / Clinical Practice / InnovateMed Author / pulmonary fibrosis

by Lori Solomon edited by Stephanie Baum, reviewed by Andrew Zinin Editors’ notes The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults. Jascayd becomes the first and only preferential phosphodiesterase 4B inhibitor with immunomodulatory and antifibrotic effects approved for this indication. The approval is based on results from

FDA approves Jascayd for progressive pulmonary fibrosis Read More »